| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/10/2001 | WO2001032224A1 Method of inactivating pathogens |
| 05/10/2001 | WO2001032221A1 Dna-vaccines based on constructs derived from the genomes of human and animal pathogens |
| 05/10/2001 | WO2001032216A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 05/10/2001 | WO2001032208A1 Adjuvanted genetic vaccines |
| 05/10/2001 | WO2001032205A1 Mucosal preventives for mastitis |
| 05/10/2001 | WO2001032204A2 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 05/10/2001 | WO2001032198A1 Prevention and treatment of biomaterial-associated infections |
| 05/10/2001 | WO2001032190A1 Antiviral composition comprising an extraction product of fava b eans |
| 05/10/2001 | WO2001032187A1 INHIBITING FtsZ PROTEIN (DE)POLYMERISATION |
| 05/10/2001 | WO2001032181A2 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| 05/10/2001 | WO2001032175A1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors |
| 05/10/2001 | WO2001032172A1 Process for formulation of carbapenem antibiotic compositions |
| 05/10/2001 | WO2001032162A1 Liver selective therapy |
| 05/10/2001 | WO2001032156A2 Methods for treating fibroproliferative diseases |
| 05/10/2001 | WO2001032154A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 05/10/2001 | WO2001032144A1 Dry powder compositions having improved dispersivity |
| 05/10/2001 | WO2001032130A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001016304A3 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/10/2001 | WO2001010459A3 Fish vaccine |
| 05/10/2001 | WO2001007469A3 Polypeptide dendrimers as unimolecular carriers of diagnostic imaging contrast agents, bioactive substances and drugs |
| 05/10/2001 | WO2001005974A3 The il-1l1 gene and polypeptide products |
| 05/10/2001 | WO2001000869A3 Arrays of catalytic or pre-catalytic nucleic acids |
| 05/10/2001 | WO2000072865A3 Antifungal combination use |
| 05/10/2001 | WO2000064488A3 Somatic transgene immunization and related methods |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | WO2000061067B1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 05/10/2001 | WO2000016745A3 Micronised pharmaceutical compositions |
| 05/10/2001 | US20010001098 Precore sequences in the 5' untranslated region of the core antigen mRNA are not present |
| 05/10/2001 | DE19953414A1 Imidazopyridinderivate als Phospodiesterase VII-Hemmer Imidazopyridine derivatives as phosphodiesterase VII inhibitor |
| 05/10/2001 | DE19953025A1 Pyrrolderivate als Phosphodiesterase VII-Hemmer Pyrrole derivatives as phosphodiesterase VII inhibitor |
| 05/10/2001 | DE19953024A1 Isoxazolderivate als Phosphodiesterase VII-Hemmer Isoxazole derivatives as phosphodiesterase VII inhibitor |
| 05/10/2001 | DE19949860A1 Clear salve for treating psoriasis, neurodermatitis and fungi comprises vaseline, juniper tar, 7.% walnut oil and almond oil |
| 05/10/2001 | CA2390025A1 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 05/10/2001 | CA2389807A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | CA2389765A1 Cpg receptor (cpg-r) and methods relating thereto |
| 05/10/2001 | CA2389693A1 Dna-vaccines based on constructs derived from the genomes of human and animal pathogens |
| 05/10/2001 | CA2389686A1 Adjuvanted genetic vaccines |
| 05/10/2001 | CA2389680A1 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 05/10/2001 | CA2389672A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | CA2389661A1 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 05/10/2001 | CA2389616A1 Liver selective therapy |
| 05/10/2001 | CA2389543A1 Hcv ns3 protease inhibitors |
| 05/10/2001 | CA2389415A1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | CA2389377A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 05/10/2001 | CA2389339A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | CA2389312A1 Heterocyclic cytotoxic agents |
| 05/10/2001 | CA2389229A1 Compounds having mif antagonist activity |
| 05/10/2001 | CA2388028A1 Method of inactivating pathogens |
| 05/10/2001 | CA2387801A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | CA2387785A1 Human transferase molecules |
| 05/10/2001 | CA2387759A1 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 05/10/2001 | CA2387754A1 10 human secreted proteins |
| 05/10/2001 | CA2387136A1 26 human secreted proteins |
| 05/10/2001 | CA2386822A1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| 05/10/2001 | CA2386641A1 32 human secreted proteins |
| 05/10/2001 | CA2383992A1 Antibiotic sultam and sultone derived oxazolidinones |
| 05/10/2001 | CA2382455A1 Nucleic acids and proteins from group b streptococcus |
| 05/09/2001 | EP1097988A1 Process for culturing cells in a monolayer |
| 05/09/2001 | EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| 05/09/2001 | EP1097942A2 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes |
| 05/09/2001 | EP1097938A1 Method for preparing form II crystals of clarithromycin |
| 05/09/2001 | EP1097937A1 N-acyl derivatives of the LL-E33288 antitumor antibiotics |
| 05/09/2001 | EP1097213A2 Vaccine against staphylococcus intoxication |
| 05/09/2001 | EP1097212A2 Anthrax vaccine |
| 05/09/2001 | EP1097210A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 05/09/2001 | EP1097172A1 Anti hepatitis c virus antibody and uses thereof |
| 05/09/2001 | EP1097159A1 Phosphinous and phosphonic acid derivatives used as medicaments |
| 05/09/2001 | EP1097150A1 Imidazolyl derivatives |
| 05/09/2001 | EP1097148A2 Polymorph of ritonavir |
| 05/09/2001 | EP1097127A1 Diacylhydrazine derivatives as integrin inhibitors |
| 05/09/2001 | EP1096952A2 Polysaccharide vaccine for staphylococcal infections |
| 05/09/2001 | EP1096949A2 Treatment of celiac disease with interleukin-15 antagonists |
| 05/09/2001 | EP1096939A1 Nocathiacin antibiotics |
| 05/09/2001 | EP1096934A1 Oxazolidinones to treat eye infections |
| 05/09/2001 | EP1096933A1 Use of an inhibitor of cytochrome p450 optionally combined with an antifungal agent for treating mycoses |
| 05/09/2001 | EP1096925A2 Use of inhibitors of prenyltransferases for for inhibiting fungal growth |
| 05/09/2001 | EP1066035A4 Substituted aromatic compounds for treatment of antibiotic resistant infections |
| 05/09/2001 | EP0813519B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/09/2001 | CN1294632A Compsns. derived from i(mycobacterium vaccae) and methods for their use |
| 05/09/2001 | CN1294628A Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup B |
| 05/09/2001 | CN1294593A Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 05/09/2001 | CN1294592A Process for preparing (-) pyridobenzoxazine carboxylic acid derivatives |
| 05/09/2001 | CN1294591A Process for prodn. of purine derivatives |
| 05/09/2001 | CN1294590A Method of 3-substituted adenines via 2-thioxanthines |
| 05/09/2001 | CN1294578A Novel naphthyl-substituted and anilide-substituted sulfonanides |
| 05/09/2001 | CN1294517A Immunoglobulin molecules having synthetic variable region and modified specificity |
| 05/09/2001 | CN1294514A Steroid derived antibiotics |
| 05/09/2001 | CN1294509A Enteric coated pharmaceutical compsn. and method of mfg. |
| 05/09/2001 | CN1294133A Process for extracting cordycepin and its preparation |
| 05/09/2001 | CN1293993A Styptic and inflammation-relieving medicine and its preparing process |
| 05/09/2001 | CN1293970A Chinese medicine for curing cold by omphalotherapy and its preparing process |
| 05/09/2001 | CN1293960A Antivirus compound medicine |
| 05/09/2001 | CN1065538C Antibiotic stalobacins |
| 05/09/2001 | CN1065524C Substituted phenyl acetanides, process for their prepn. and intermediates thereof |
| 05/08/2001 | US6229025 Process for alkylating hindered sulfonamides |
| 05/08/2001 | US6229008 α-D-pentofuranosides, and a process for preparing the same |
| 05/08/2001 | US6229001 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 05/08/2001 | US6228987 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 05/08/2001 | US6228983 Peptides from transmembrane protein, gp41, from human immunodeficiency virus; viricides; drug screening; intracellular modulators of coiled-coil peptide structures |